Literature DB >> 7594581

Functional expression of CD40 antigen on human epidermal Langerhans cells.

J Péguet-Navarro1, C Dalbiez-Gauthier, F M Rattis, C Van Kooten, J Banchereau, D Schmitt.   

Abstract

It is now well established that interactions of CD40 on the B cells, along with its ligand (CD40-L) on the T cells, regulate B cell proliferation and differentiation. However, the functional significance of CD40 expression on cells known for most efficient Ag-presenting function, i.e., dendritic cells, is not so clear. In this study, we demonstrate that CD40 is expressed on human dendritic Langerhans cells (LC) freshly isolated from epidermis. Using CD40-L transfected cells, CD40 triggering was found to enhance LC viability when cultured and to result in phenotypic alterations. Thus, a 2-day CD40 activation induced up-regulation of CD54 and CD86 at the LC surface, while it did not significantly affect the levels of HLA-DR, CD1a, CD58, and CD80 expression. These phenotypic changes correlate with enhanced LC allostimulatory property, as shown by the use of paraformaldehyde-fixed LC. Furthermore, mAbs against CD40, as well as CD40-L, strongly inhibit the primary T cell response to allogeneic LC. Collectively, these data support a role for CD40/CD40-L pair in the development of normal T cell functions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7594581

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Acquisition of immune function during the development of the Langerhans cell network in neonatal mice.

Authors:  A L Dewar; K V Doherty; G M Woods; A B Lyons; H K Muller
Journal:  Immunology       Date:  2001-05       Impact factor: 7.397

2.  Murine AIDS requires CD154/CD40L expression by the CD4 T cells that mediate retrovirus-induced disease: Is CD4 T cell receptor ligation needed?

Authors:  Wen Li; William R Green
Journal:  Virology       Date:  2006-11-17       Impact factor: 3.616

3.  Incorporation of CD40 ligand into SHIV virus-like particles (VLP) enhances SHIV-VLP-induced dendritic cell activation and boosts immune responses against HIV.

Authors:  Rongxin Zhang; Sheng Zhang; Min Li; Changyi Chen; Qizhi Yao
Journal:  Vaccine       Date:  2010-05-14       Impact factor: 3.641

Review 4.  The CD40 ligand. At the center of the immune universe?

Authors:  I S Grewal; R A Flavell
Journal:  Immunol Res       Date:  1997-02       Impact factor: 2.829

5.  Intravenously usable fully serotype 3 oncolytic adenovirus coding for CD40L as an enabler of dendritic cell therapy.

Authors:  Sadia Zafar; Suvi Parviainen; Mikko Siurala; Otto Hemminki; Riikka Havunen; Siri Tähtinen; Simona Bramante; Lotta Vassilev; Hongjie Wang; Andre Lieber; Silvio Hemmi; Tanja de Gruijl; Anna Kanerva; Akseli Hemminki
Journal:  Oncoimmunology       Date:  2016-12-07       Impact factor: 8.110

6.  Induction of dendritic cell costimulator molecule expression is suppressed by T cells in the absence of antigen-specific signalling: role of cluster formation, CD40 and HLA-class II for dendritic cell activation.

Authors:  A D McLellan; A Heiser; D N Hart
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

7.  DEC-205lo Langerinlo neonatal Langerhans' cells preferentially utilize a wortmannin-sensitive, fluid-phase pathway to internalize exogenous antigen.

Authors:  Bernadette M Bellette; Gregory M Woods; Teresa Wozniak; Kathleen V Doherty; H Konrad Muller
Journal:  Immunology       Date:  2003-12       Impact factor: 7.397

8.  Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4.

Authors:  T G Markees; N E Phillips; E J Gordon; R J Noelle; L D Shultz; J P Mordes; D L Greiner; A A Rossini
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

9.  Uncoupling of induced protein processing from maturation in dendritic cells exposed to a highly antigenic preparation from a helminth parasite.

Authors:  Fraser A Marshall; Edward J Pearce
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

10.  CD40L coding oncolytic adenovirus allows long-term survival of humanized mice receiving dendritic cell therapy.

Authors:  Sadia Zafar; Suvi Sorsa; Mikko Siurala; Otto Hemminki; Riikka Havunen; Victor Cervera-Carrascon; João Manuel Santos; Hongjie Wang; Andre Lieber; Tanja De Gruijl; Anna Kanerva; Akseli Hemminki
Journal:  Oncoimmunology       Date:  2018-08-15       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.